Egg Freezing in Dubai: Age at Retrieval, Mature Oocyte Numbers, and How to Interpret Live-Birth Data

Age at retrieval and the number of mature (MII) oocytes matter far more than how many total eggs were collected, and published live-birth figures represent statistical probabilities, not a guaranteed clinical recipe.

What does “egg freezing” actually preserve?

Egg freezing preserves mature oocytes at the chromosomal and biological age of the woman on the day of retrieval. While rapid vitrification arrests cellular aging in storage, cryopreservation mitigates age-related fertility decline rather than eliminating it or guaranteeing a future baby.

In clinical practice, planned oocyte cryopreservation, often termed elective egg freezing when undertaken to protect against future age-related decline, relies on vitrification. This laboratory technique cools mature oocytes so quickly that water molecules solidify without forming destructive ice crystals, protecting the cell's delicate architecture until thaw.

However, vitrification only preserves the cellular potential that was present at aspiration. It does not repair pre-existing chromosomal errors, reverse mitochondrial decline, or alter the natural attrition that occurs during thaw, fertilization, and embryonic development. Understanding what egg freezing can and cannot achieve is the foundation of thoughtful family planning.

How does age at retrieval change live-birth chances?

Age at retrieval is the primary biological factor governing oocyte chromosomal competence and subsequent live-birth potential. As chronological age advances, the proportion of eggs with meiotic errors increases, meaning that an oocyte vitrified at age 32 has a higher statistical probability of resulting in a live birth than one vitrified at age 40.

Ovarian aging involves two parallel pathways: a gradual reduction in the number of resting follicles and a progressive decline in oocyte nuclear and cytoplasmic quality. While clinical literature frequently identifies the best age for egg freezing as prior to age 35, when aneuploidy rates are lowest, reproductive senescence exists along a continuous curve rather than an absolute chronological cliff.

One of the largest single-centre series of women who actually returned to use their frozen eggs (Cascante et al., 2024; 731 patients, New York University Langone Fertility Center) shows how age at first freezing influences the cumulative live-birth rate per patient:

Data from Cascante et al. (2024). Overall cumulative live birth / ongoing pregnancy rate: 43% (313 of 731 patients). Median age at first freezing was 38 years and median age at first thaw 42 years; women thawed a median of 12 mature oocytes. Ongoing pregnancies beyond 12 weeks were counted together with live births.

Crucially, age and egg number act together. In multivariable analysis, both age at first freezing and the total number of mature oocytes thawed independently predicted live birth, whereas the number of stimulation cycles did not, additional cycles help only because they add oocytes. The highest rates (above 70%) were seen in women who thawed 20 or more mature oocytes frozen before the age of 38 (Cascante et al., 2024).

Importantly, these figures stem from a single large academic center in the United States, include some older slow-frozen oocytes, and are not outcome benchmarks recorded in Dubai. As the American Society for Reproductive Medicine has emphasized, there is insufficient evidence to specify an absolute number of oocytes that guarantees a live birth after planned oocyte cryopreservation (ASRM, 2021).

What do population-level registry data show?

A national registry study published in Human Reproduction in 2026 followed all 20,209 women who undertook planned egg freezing in Australia and New Zealand between 2009 and 2023 (Fitzgerald et al., 2026). Women typically froze their eggs between the ages of 34 and 38. Among women with at least ten years of follow-up, 27.9% returned to thaw their eggs, on average 4.9 years after freezing; nearly half of those who used their eggs (47%) did so with donor sperm.

Among women who thawed their eggs, 33.9% achieved at least one live birth, rising to 37.8% for eggs thawed between 2019 and 2021. Age at freezing and the number of eggs thawed were associated with the chance of a live birth, while the length of time the eggs had been stored was not. These registry results reflect real-world outcomes across many clinics rather than a single specialist centre, a useful counterweight to more optimistic projections.

How many mature (MII) oocytes, and how to read those numbers?

The true unit of biological value in egg freezing is the Metaphase II (MII) oocyte, not the gross number of follicles punctured or total eggs aspirated. Establishing realistic expectations requires looking at mature oocytes that have extruded the first polar body, as only these cells possess the developmental capacity to fertilize.

When patients ask how many eggs to freeze, the honest answer is that it depends on age. A given number of mature oocytes carries a very different prognosis at 32 than at 40, which is why figures quoted for egg-number brackets without reference to age can be misleading. Any estimate should therefore combine both variables.

One widely used tool that does this is the BWH Egg Freezing Counseling Tool (EFCT), developed at Brigham and Women’s Hospital (Goldman et al., 2017). It estimates the probability of at least one live birth according to age at freezing (24 to 44 years) and the number of mature eggs frozen. It is a helpful starting point for a conversation, but it is not externally validated, and it was built on data from IVF patients and egg donors rather than women who froze eggs electively. Data from women who actually thawed their eggs suggest that such models may overestimate success, particularly in younger women (Cascante et al., 2024). For example, for a woman freezing at 34, the EFCT predicts live-birth chances of about 50%, 75%, 88% and 94% with 6, 12, 18 and 24 mature eggs, whereas the Cascante model, based on real thaw outcomes, predicts approximately 42%, 52%, 62% and 71%.

Calculator results should therefore be interpreted together with your physician, alongside your ovarian reserve, family-building goals and the laboratory’s own outcomes.

What live-birth statistics actually measure (and what they do not)?

Live-birth statistics derived from clinical studies measure mathematical probabilities across broad cohorts, not an individual guarantee. Furthermore, online calculators may skew high because many rely on data extrapolated from IVF patients with normal ovarian reserve and young egg donors rather than autologous patients freezing later in their reproductive window.

When reading reproductive outcome data, two metrics must be separated:

• Surrogate Endpoints (Oocyte Yield, AMH, Fertilization): Biomarkers such as Anti-Müllerian Hormone (AMH) and Antral Follicle Count (AFC) predict ovarian response and total egg yield during stimulation. They do not predict oocyte ploidy, embryonic development, or live birth.
• True Clinical Endpoints (Live Birth per Thawed Cohort): The definitive measure is whether a vitrified cohort leads to a healthy delivery. A high egg retrieval count offers reassurance regarding volume, but it does not bypass the biological attrition that takes place from thaw to blastocyst formation.

Cryopreservation duration itself does not appear to compromise results. Observational data indicate that storage in liquid nitrogen (−196°C) does not alter survival, fertilization, or pregnancy rates (ASRM, 2021), and in the Australian and New Zealand registry the length of storage was not associated with the chance of a live birth (Fitzgerald et al., 2026). The deciding factor is the woman’s age when the eggs were collected, not how long they remain in the cryotank.

Why the laboratory matters

Egg freezing is an exceptionally delicate laboratory procedure. Mature human oocytes are among the most challenging cells to freeze and thaw successfully, largely because of their size, high water content and the sensitivity of their internal structures. Every step matters, from the handling of oocytes immediately after retrieval, through the timing of vitrification (the rapid-freezing technique used today), to the precise laboratory procedures followed during warming. The experience of the embryology team, the quality of the laboratory protocols and careful attention to seemingly small details can make a substantial difference.

One important measure of laboratory performance is the oocyte survival rate, the proportion of frozen eggs that remain viable after warming. But survival alone is not the whole story. An oocyte must also retain its ability to fertilise normally and support healthy embryo development. This is why choosing a clinic for egg freezing should involve more than comparing prices or the number of eggs expected to be collected. The quality and experience of the embryology laboratory are just as important as the number of eggs you freeze.

What to assess before a cycle in Dubai (biology, not a clinic brochure)

A meaningful pre-cycle consultation centers on individual ovarian physiology, baseline reproductive reserve, and personal family timelines, rather than marketing claims or generic package guarantees.

Before initiating stimulation, clinical assessment focuses on:

• Baseline Reserve Markers: Serum AMH and an accurate transvaginal Antral Follicle Count (AFC) establish expected egg yield per cycle and dictate safe gonadotropin dosing.
• Realistic Cycle Planning: For women over 37 or those with low baseline reserve, a comprehensive strategy may involve discussing sequential or dual-stimulation cycles to accumulate an adequate pool of mature MII oocytes. Additional cycles improve the chances only insofar as they increase the total number of mature eggs stored.
• The Clinical Pathway in Perspective: Controlled stimulation and transvaginal retrieval represent a brief clinical intervention, typically 10 to 12 days of individualized hormone administration followed by an outpatient aspiration under light sedation.
• Regulatory Context: Eligibility requirements, storage timelines, and the future utilization of cryopreserved oocytes are defined by current UAE health regulations and clinical governance policies. Specific criteria regarding marital status at the time of thaw, embryo creation, and transfer must be confirmed directly with your treating physician and clinic during initial consultation.
• Sperm Contribution at Thaw: While egg freezing preserves the maternal half of the equation, eventual embryo quality and live-birth rates also depend on the paternal semen parameters evaluated at the time of future fertilization.

Frequently Asked Questions

What is the most biologically favorable age to freeze eggs?

From a biological perspective, the most favourable age to freeze eggs is between 25 and 30, when oocyte quality and chromosomal normality are generally highest. Egg quality declines gradually with age, with the decline becoming more pronounced from the mid-30s onwards.

Egg freezing remains a reasonable option between 35 and 40, although the likelihood of achieving a live birth from each frozen egg decreases with age. Women in this age group may therefore need to freeze a larger number of mature oocytes to achieve a reasonable chance of future pregnancy. This often requires more than one cycle of ovarian stimulation and egg retrieval.

How many mature eggs do I need to freeze to guarantee a baby?

No number of frozen oocytes can guarantee a live birth. The number needed for a reasonable chance depends above all on your age at freezing: the same number of eggs offers considerably better prospects at 32 than at 40. Tools such as the BWH Egg Freezing Counseling Tool can give an age-specific estimate, but they may be optimistic and should be discussed with your physician.

Do I need to be married to freeze my eggs in the UAE?

Eligibility for oocyte cryopreservation and the later use of stored oocytes follow current UAE regulation and must be confirmed directly with your treating clinic. This is discussed in more detail in our dedicated Q&A: “Do I need to be married to freeze my eggs in the UAE?”

How many women actually use their frozen eggs?

Fewer than many expect. In Australia and New Zealand, just over one in four women (27.9%) had returned to thaw their eggs within ten years of freezing, on average about five years later (Fitzgerald et al., 2026). Many conceive naturally or decide on a different path, egg freezing is best seen as an option kept open, not a plan that must be used.

Do my eggs age or degrade while stored in the cryobank?

No. Vitrification halts biological and metabolic activity by maintaining the cells in liquid nitrogen at −196°C. Current clinical evidence indicates that the length of storage does not reduce post-thaw survival, fertilization, or the chance of a live birth.

Does having low AMH mean egg freezing is not worth doing?

A low AMH level indicates reduced ovarian reserve and suggests that fewer eggs will be retrieved in an individual stimulation cycle; it does not indicate poor egg quality. Quality correlates primarily with maternal age. Women with low AMH can still freeze eggs, though they may require personalized stimulation protocols or multiple cycles to collect an adequate cohort of mature oocytes.

References

1. Practice Committee of the American Society for Reproductive Medicine. Evidence-based outcomes after oocyte cryopreservation for donor oocyte in vitro fertilization and planned oocyte cryopreservation: a guideline. Fertil Steril. 2021;116(1):36-47.
2. Anderson RA, Amant F, Braat D, et al. ESHRE guideline: female fertility preservation. Hum Reprod Open. 2020;2020(4):hoaa052.
3. Cascante SD, Grifo JA, Licciardi F, Parra CM, Kelly A, Berkeley AS. The effects of age, mature oocyte number, and cycle number on cumulative live birth rates after planned oocyte cryopreservation. J Assist Reprod Genet. 2024;41:2979-2985. doi:10.1007/s10815-024-03175-w
4. Fitzgerald O, Keller E, Illingworth P, et al. Planned egg freezing over 15 years: return to treatment and success rates in Australia and New Zealand. Hum Reprod. 2026; advance article. doi:10.1093/humrep/deag155
5. Goldman RH, Racowsky C, Farland LV, Munné S, Ribustello L, Fox JH. Predicting the likelihood of live birth for elective oocyte cryopreservation: a counseling tool for physicians and patients. Hum Reprod. 2017;32(4):853-859.
6. Fox J, Goldman R. BWH Egg Freezing Counseling Tool (EFCT). MDCalc. https://www.mdcalc.com/calc/3937/bwh-egg-freezing-counseling-tool-efct
7. von Wolff M, Nawroth F, eds. Fertility Preservation in Oncological and Non-Oncological Diseases: A Practical Guide. Springer Nature; 2020.

Disclaimer: This article is for general educational purposes only and does not constitute medical advice, formal diagnosis, or a treatment recommendation. Healthcare choices and clinical pathways must be determined in direct consultation with a licensed reproductive endocrinologist following a comprehensive, individualized medical assessment.

About the author

Dr Ewa Goncikowska, MD, PhD

Specialist in Gynaecological Endocrinology, Reproduction & Infertility